Chicago Atlantic BDC Inc

Análisis de la acción Chicago Atlantic BDC Inc (LIEN)

$10.200

+0.060 (+0.59%)Al cierre

Loading chart…
High
10.260
Open
10.190
VWAP
10.19
Vol
37.80K
Mkt Cap
Low
10.120
Amount
385.29K
EV/EBITDA, TTM
511.02

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors.

AI analysis of Chicago Atlantic BDC Inc (LIEN)

buy

Chicago Atlantic BDC Inc (LIEN) appears to be a good buy right now, primarily driven by its strong fundamentals and favorable technical indicators. The current price is $10.20, and the forward P/E ratio is notably low at 6.42, suggesting that the stock is undervalued compared to its earnings potential. Additionally, the company has a robust dividend yield expectation of 13.19%, which is attractive for long-term investors seeking income. However, the main risk is the recent earnings report showing a 15% EPS surprise to the downside, which could affect short-term sentiment.

Métricas de valoración

The current forward P/E ratio for Chicago Atlantic BDC Inc (LIEN) is 6.42, compared to its 5-year average forward P/E of 6.68.

Forward P/E

Fair
5Y Average P/E
6.68
Current P/E
6.42
Sobrevalorada
7.31
Infravalorada
6.05

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
25.45
Current EV/EBITDA
511.02
Sobrevalorada
147.72
Infravalorada
-96.81

Forward P/S

Fair
5Y Average P/S
3.34
Current P/S
3.43
Sobrevalorada
3.56
Infravalorada
3.13

Alphio AI Price Scenarios for LIEN

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%LIEN

$10.25

Precio del escenario

B

Base

Base · 50%LIEN

$9.62

Precio del escenario

B

Bear

Bear · 25%LIEN

$7.94

Precio del escenario

Cronología de eventos

2026-05-11 (ET)

16:20:00

Chicago Atlantic BDC Files for $500M Securities Registration

2026-03-19 (ET)

07:10:00

Chicago Atlantic BDC Reports $14.2M Investment Income

2025-11-13 (ET)

07:15:20

Chicago Atlantic BDC Announces Q3 NII per Share of 42 Cents, Up from 34 Cents Last Quarter

2025-08-14 (ET)

07:07:36

Chicago Atlantic BDC reports Q2 NII 34c vs. 38c last year

2025-05-14 (ET)

07:14:32

Chicago Atlantic BDC reports Q1 EPS 33c vs 35c last year

Noticias

LIEN FAQ — answered by Alphio AI

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors. It operates in the Financials sector.

Chicago Atlantic BDC Inc (LIEN) appears to be a good buy right now, primarily driven by its strong fundamentals and favorable technical indicators. The current price is $10.20, and the forward P/E ratio is notably low at 6.42, suggesting that the stock is undervalued compared to its earnings potential. Additionally, the company has a robust dividend yield expectation of 13.19%, which is attractive for long-term investors seeking income. However, the main risk is the recent earnings report showing a 15% EPS surprise to the downside, which could affect short-term sentiment.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis